SRPT

NASDAQStock

Sarepta Therapeutics, Inc.

$16.53-0.50 (-2.93%)

52-Week Range

$11.93
$101.35

Key Stats

Market Cap

1.7B

P/E Ratio

Dividend Yield

Beta

0.46

Volume

1.4M

Avg Volume

2.6M

Performance

1M

-4.22%

3M

-20.93%

6M

-5.86%

YTD

-20.04%

1Y

-83.19%

3Y

-88.61%

5Y

-79.82%

Price Chart

ETF Exposure

SRPT is held by 164 ETFs

ETFFund NameWeight
AVSUAvantis Responsible U.S. Equity ETF0.00%
AVUSAvantis U.S. Equity ETF0.00%
CHEPAGFiQ U.S. Market Neutral Value Fund0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
IRTRiShares LifePath Retirement ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
MMTMState Street SPDR S&P 1500 Momentum Tilt ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
PreviousPage 4 of 4

About SRPT ETF Exposure

Sarepta Therapeutics, Inc. (SRPT) is held by 164 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.7B, SRPT is a widely held institutional stock. The stock currently trades at $16.53. Investors can gain exposure to SRPT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold SRPT, sorted by portfolio weight.